Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein K27-linked ubiquitination	UBE2D2 UBE2D3 UBR4 UBE2D4	8.28e-06	14	202	4	GO:0044314
Domain	-	PSG2 CADM4 SIRPG NEO1 PVR ASTN2 TRIM36 USH2A CNTFR CDON FLT1 TNC FSD2 BTLA PKHD1L1 CD8B SIGLEC6 VCAN PLXNA4 CNTN3 TGM7	6.32e-06	663	195	21	2.60.40.10
Domain	Ig-like_fold	PSG2 CADM4 SIRPG NEO1 PVR ASTN2 TRIM36 USH2A CNTFR CDON FLT1 TNC FSD2 BTLA PKHD1L1 CD8B SIGLEC6 VCAN PLXNA4 CNTN3 TGM7	1.63e-05	706	195	21	IPR013783
Domain	WD40_repeat_dom	DCAF8 NBEAL1 DDB1 MAPK8IP3 CDC40 POC1B WDFY1 UBR4 NBEA WDPCP DNAI1 TENM3	7.05e-05	297	195	12	IPR017986
Domain	FN3	NEO1 ASTN2 TRIM36 USH2A CNTFR CDON TNC FSD2 CNTN3	1.45e-04	185	195	9	SM00060
Domain	ig	PSG2 SIRPG PVR CNTFR CDON FLT1 BTLA SIGLEC6 CNTN3	1.77e-04	190	195	9	PF00047
Domain	Immunoglobulin	PSG2 SIRPG PVR CNTFR CDON FLT1 BTLA SIGLEC6 CNTN3	1.77e-04	190	195	9	IPR013151
Domain	-	DCAF8 NBEAL1 DDB1 MAPK8IP3 CDC40 POC1B SEMA6A WDFY1 NBEA WDPCP DNAI1 PLXNA4	2.06e-04	333	195	12	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DCAF8 NBEAL1 DDB1 MAPK8IP3 CDC40 POC1B SEMA6A WDFY1 NBEA WDPCP DNAI1 PLXNA4	2.17e-04	335	195	12	IPR015943
Domain	FN3	NEO1 ASTN2 TRIM36 USH2A CNTFR CDON TNC FSD2 CNTN3	2.50e-04	199	195	9	PS50853
Domain	Ig_V-set	PSG2 CADM4 SIRPG PVR FLT1 CD8B SIGLEC6 VCAN CNTN3	2.50e-04	199	195	9	IPR013106
Domain	fn3	NEO1 TRIM36 USH2A CNTFR CDON TNC FSD2 CNTN3	3.07e-04	162	195	8	PF00041
Domain	FN3_dom	NEO1 ASTN2 TRIM36 USH2A CNTFR CDON TNC FSD2 CNTN3	3.59e-04	209	195	9	IPR003961
Domain	IG	PSG2 CADM4 SIRPG NEO1 PVR CNTFR CDON FLT1 BTLA CD8B SIGLEC6 VCAN CNTN3	4.99e-04	421	195	13	SM00409
Domain	Ig_sub	PSG2 CADM4 SIRPG NEO1 PVR CNTFR CDON FLT1 BTLA CD8B SIGLEC6 VCAN CNTN3	4.99e-04	421	195	13	IPR003599
Domain	CH	SPTB SPTBN1 ACTN4 NAV3 LMO7	5.86e-04	65	195	5	SM00033
Domain	Spectrin_bsu	SPTB SPTBN1	6.42e-04	4	195	2	IPR016343
Domain	V-set	PSG2 CADM4 SIRPG PVR CD8B SIGLEC6 VCAN CNTN3	7.15e-04	184	195	8	PF07686
Domain	CH	SPTB SPTBN1 ACTN4 NAV3 LMO7	8.23e-04	70	195	5	PF00307
Domain	-	SAMD9 ZGRF1 CHD1 ABCB4 SUPV3L1 ABCC8 SHPRH NAV3 DNAH6 CARD14 EP400 SEPTIN5 DDX51 MSH4 RHEB ORC4 DDX20 AQR	8.50e-04	746	195	18	3.40.50.300
Domain	-	SPTB SPTBN1 ACTN4 NAV3 LMO7	8.78e-04	71	195	5	1.10.418.10
Domain	Helicase_C	CHD1 SUPV3L1 SHPRH EP400 DDX51 DDX20	9.05e-04	107	195	6	PF00271
Domain	HELICc	CHD1 SUPV3L1 SHPRH EP400 DDX51 DDX20	9.05e-04	107	195	6	SM00490
Domain	Helicase_C	CHD1 SUPV3L1 SHPRH EP400 DDX51 DDX20	9.50e-04	108	195	6	IPR001650
Domain	CH	SPTB SPTBN1 ACTN4 NAV3 LMO7	9.96e-04	73	195	5	PS50021
Domain	HELICASE_CTER	CHD1 SUPV3L1 SHPRH EP400 DDX51 DDX20	9.97e-04	109	195	6	PS51194
Domain	HELICASE_ATP_BIND_1	CHD1 SUPV3L1 SHPRH EP400 DDX51 DDX20	9.97e-04	109	195	6	PS51192
Domain	DUF4704	NBEAL1 NBEA	1.06e-03	5	195	2	IPR031570
Domain	DUF4704	NBEAL1 NBEA	1.06e-03	5	195	2	PF15787
Domain	CH-domain	SPTB SPTBN1 ACTN4 NAV3 LMO7	1.13e-03	75	195	5	IPR001715
Pubmed	Ubiquitination of STING at lysine 224 controls IRF3 activation.	UBE2D2 UBE2D3 MUL1 UBE2D4	7.58e-07	13	202	4	28763789
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	ITGA6 ACTN4 FAT1 PI4KA PVR PIP5K1A VASP HSPA9 FLT1 TNC LMO7	1.01e-06	285	202	11	21423176
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CYP1B1 ACTN4 SQOR DDB1 DDOST FAT1 NEO1 NDUFA12 PRDX3 PVR PIP5K1A NID1 LOXL3 DNAH6 HSPA9 CERS2 COX7A2P2 CP CPT2 TMBIM6 ASH2L RHEB RSBN1 FRRS1 MEPCE	1.29e-06	1451	202	25	30550785
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SAMD9 C15orf39 DDOST RUSC2 TYK2 FREM2 CDC40 SUPV3L1 PIP5K1A KYNU MGRN1 NOL9 ASH2L JMJD1C IBTK AQR	1.49e-06	650	202	16	38777146
Pubmed	Identification of a novel cell-adhesive protein spatiotemporally expressed in the basement membrane of mouse developing hair follicle.	FREM2 NID1 COL4A6 TNC	1.90e-06	16	202	4	15878328
Pubmed	The RING domain of mitochondrial E3 ubiquitin ligase 1 and its complex with Ube2D2: crystallization and X-ray diffraction.	UBE2D2 UBE2D3 MUL1	1.91e-06	5	202	3	31929179
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	NID1 CDON TNC LAMA2 APOB VCAN	2.02e-06	64	202	6	22261194
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	ZNF235 SQOR SHPRH MED12L HSPA9 FLT1 INTS7 JMJD1C IBTK TENM3 LMO7 EIF4E	2.05e-06	371	202	12	15747579
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	DDB1 PRDX3 SIPA1L2 HSPA9 CARD14 EP400 UBR4 ZBTB47 IBTK RESF1 DDX20 PRORP	3.99e-06	396	202	12	26687479
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	CYP1B1 GBF1 NT5C3A ITGA6 FAT1 NEO1 NDUFA12 PVR MUL1 KYNU TNFSF15 VASP HSPA9 MGRN1 CERS2 APOB RHEB ORC4 LMO7 C15orf61	4.31e-06	1061	202	20	33845483
Pubmed	Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.	SPTBN1 ACTN4 SQOR DDB1 PI4KA NAV3 CC2D2A C3 HSPA9 EP400 FAM83H VPS13D FRRS1 VCAN	6.24e-06	564	202	14	21565611
Pubmed	The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor.	UBE2D2 UBE2D3 UBE2D4	6.64e-06	7	202	3	21685362
Pubmed	Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.	UBE2D2 UBE2D3 UBE2D4	6.64e-06	7	202	3	30884854
Pubmed	Localization of extracellular matrix receptors in ICGN mice, a strain of mice with hereditary nephrotic syndrome.	ITGA6 TNC RP1	6.64e-06	7	202	3	11767049
Pubmed	Bifunctional apoptosis regulator (BAR), an endoplasmic reticulum (ER)-associated E3 ubiquitin ligase, modulates BI-1 protein stability and function in ER Stress.	UBE2D2 UBE2D3 TMBIM6	6.64e-06	7	202	3	21068390
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	CYP1B1 MAK DCAF8 ACP5 SPTBN1 SNRK ACTN4 DDOST FAT1 RRP7A C3 CA1 TNC BBS5 CUBN ORC4 VCAN ZNF566 MEPCE NIPAL2 DEPDC5 PRORP	7.14e-06	1293	202	22	15342556
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	SPTBN1 DDB1 SHPRH NID1 FLT1 HTR2B FNBP4 NBEA DNAI1 VPS13D LMO7 MEPCE RP1	7.74e-06	497	202	13	36774506
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	GBF1 ELP6 CYP46A1 FCHO1 FAT1 DNAH6 UBR4 CALCOCO1 JMJD1C MICU3 LMO7	9.63e-06	361	202	11	26167880
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 GBF1 ZNF280D SPTBN1 CHD1 ACTN4 DDB1 DDOST HNRNPL CDC40 SUPV3L1 PI4KA PRDX3 CC2D2A RRP7A NOP2 HSPA9 UBR4 APOB NOL9 EIF4E DDX20 AQR	1.02e-05	1425	202	23	30948266
Pubmed	Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase.	UBE2D2 UBE2D3 UBE2D4	1.06e-05	8	202	3	28681414
Pubmed	Ube2W conjugates ubiquitin to α-amino groups of protein N-termini.	UBE2D2 UBE2D3 UBE2D4	1.06e-05	8	202	3	23560854
Pubmed	Inhibition of UVSSA ubiquitination suppresses transcription-coupled nucleotide excision repair deficiency caused by dissociation from USP7.	UBE2D2 UBE2D3 UBE2D4	1.06e-05	8	202	3	29323787
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DDB1 CEP350 PIP5K1A SIPA1L2 INTS7 JMJD1C ORC4 MEPCE DDX20	1.33e-05	242	202	9	34011540
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TRPM6 SPTBN1 ACTN4 ALKBH8 KCNH1 PI4KA WDFY1 CERS2 BTLA APOB NOL9 CUBN CPT2 TMBIM6 ASH2L ORC4 RESF1 VCAN TRAPPC10	2.07e-05	1084	202	19	11544199
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	FREM2 NEO1 PVR C3 TNC LAMA2 CP APOB CNTN3	2.13e-05	257	202	9	16335952
Pubmed	Mechanism and chain specificity of RNF216/TRIAD3, the ubiquitin ligase mutated in Gordon Holmes syndrome.	UBE2D2 UBE2D3 UBE2D4	2.25e-05	10	202	3	31087003
Pubmed	Osmotic and heat stress-dependent regulation of MLK4β and MLK3 by the CHIP E3 ligase in ovarian cancer cells.	UBE2D2 UBE2D3 UBE2D4	2.25e-05	10	202	3	28757353
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	NBEAL1 HNRNPL CAPN13 FREM2 DCANP1 FAT1 PVR ERVK-25 COL4A6 FLT1 BTLA LMO7 ZFHX2	2.33e-05	552	202	13	10737800
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	DCAF8 SPTBN1 HNRNPL PI4KA NAV3 NID1 C3 NOP2 CACNA1B INTS7 UBR4 DDX20	2.45e-05	475	202	12	31040226
Pubmed	Functional analysis of secreted and transmembrane proteins critical to mouse development.	ITGA6 FAT1 NEO1 SEMA6A	3.07e-05	31	202	4	11431694
Pubmed	Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2.	DCAF8 DDB1 UBE2D3	3.08e-05	11	202	3	37379210
Pubmed	Monoubiquitinated histone H2A destabilizes photolesion-containing nucleosomes with concomitant release of UV-damaged DNA-binding protein E3 ligase.	DDB1 UBE2D2 UBE2D3	3.08e-05	11	202	3	22334663
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DPP10 EP400 PHF12 CALCOCO1 TENM3 CNTN3	3.19e-05	103	202	6	10819331
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	CC2D2A SEMA6A SIPA1L2 WDFY1 UBR4 JMJD1C IBTK	3.33e-05	153	202	7	10718198
Pubmed	Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity.	UBE2D2 UBE2D4	3.36e-05	2	202	2	26912277
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	3.36e-05	2	202	2	16493581
Pubmed	Molecular cloning of Lyt-3, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to immunoglobulin and T-cell receptor variable and joining regions.	CD8B CD8B2	3.36e-05	2	202	2	3035575
Pubmed	Molecular characterization of the murine cytotoxic T-cell membrane glycoprotein Ly-3 (CD8).	CD8B CD8B2	3.36e-05	2	202	2	3498943
Pubmed	An immunological role for the CD8 beta-chain.	CD8B CD8B2	3.36e-05	2	202	2	1534146
Pubmed	[Semaphorin/plexin signal regulates lamina-restricted projection of hippocampal mossy fiber].	SEMA6A PLXNA4	3.36e-05	2	202	2	21089322
Pubmed	Duality of the murine CD8 compartment.	CD8B CD8B2	3.36e-05	2	202	2	24594598
Pubmed	Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain.	CD8B CD8B2	3.36e-05	2	202	2	7889415
Pubmed	AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas.	CD8B CD8B2	3.36e-05	2	202	2	3025647
Pubmed	Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants.	CD8B CD8B2	3.36e-05	2	202	2	2452747
Pubmed	Distinct methylation states of the CD8 beta gene in peripheral T cells and intraepithelial lymphocytes.	CD8B CD8B2	3.36e-05	2	202	2	9233619
Pubmed	Genetic Variability in the Iron Homeostasis Pathway and Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.	CP CUBN	3.36e-05	2	202	2	32246437
Pubmed	Stalk region of beta-chain enhances the coreceptor function of CD8.	CD8B CD8B2	3.36e-05	2	202	2	12847256
Pubmed	The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.	APOF APOB	3.36e-05	2	202	2	22363685
Pubmed	Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice.	C3 LAMA2	3.36e-05	2	202	2	12044978
Pubmed	Transcriptional diversity at the duplicated human CD8 beta loci.	CD8B CD8B2	3.36e-05	2	202	2	8436166
Pubmed	Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling.	UBE2D2 MUL1	3.36e-05	2	202	2	18213395
Pubmed	Structure and expression of the Lyt-3a gene of C.AKR mice.	CD8B CD8B2	3.36e-05	2	202	2	3169881
Pubmed	Esr, a second locus in the house mouse controlling esterase-5.	CD8B CD8B2	3.36e-05	2	202	2	7103930
Pubmed	The phosphatidylinositol 4-kinase PI4KIIIalpha is required for the recruitment of GBF1 to Golgi membranes.	GBF1 PI4KA	3.36e-05	2	202	2	20530568
Pubmed	Agonist-stimulated phosphatidylinositol-3,4,5-trisphosphate generation by scaffolded phosphoinositide kinases.	PI4KA PIP5K1A	3.36e-05	2	202	2	27870828
Pubmed	Exome sequencing in patients with microphthalmia, anophthalmia, and coloboma (MAC) from a consanguineous population.	CDON TENM3	3.36e-05	2	202	2	32799327
Pubmed	Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes.	CD8B CD8B2	3.36e-05	2	202	2	5558567
Pubmed	Cloning and modeling of CD8 beta in the amphibian ambystoma Mexicanum. Evolutionary conserved structures for interactions with major histocompatibility complex (MHC) class I molecules.	CD8B CD8B2	3.36e-05	2	202	2	12034498
Pubmed	Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer.	SEMA6A PLXNA4	3.36e-05	2	202	2	34815265
Pubmed	Requirement for CD8 beta chain in positive selection of CD8-lineage T cells.	CD8B CD8B2	3.36e-05	2	202	2	8108731
Pubmed	Murine Ly-3 restriction fragment length polymorphism and transcript size differences.	CD8B CD8B2	3.36e-05	2	202	2	2576243
Pubmed	The cytoplasmic domain of CD8 beta regulates Lck kinase activation and CD8 T cell development.	CD8B CD8B2	3.36e-05	2	202	2	9647223
Pubmed	The IB-peptide marker and the Ly-3 surface alloantigen: structural studies of a V kappa-region polymorphism and a T-cell marker determined by linked genes.	CD8B CD8B2	3.36e-05	2	202	2	408079
Pubmed	Bax Inhibitor-1 regulates hepatic lipid accumulation via ApoB secretion.	APOB TMBIM6	3.36e-05	2	202	2	27297735
Pubmed	Characterization of the mouse CD8 beta chain-encoding gene promoter region.	CD8B CD8B2	3.36e-05	2	202	2	8781121
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	3.36e-05	2	202	2	15073129
Pubmed	Ubiquitin ligase defect by DCAF8 mutation causes HMSN2 with giant axons.	DCAF8 DDB1	3.36e-05	2	202	2	24500646
Pubmed	Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunction.	CYP1B1 C3 KYNU HTR2B TNC CP	3.56e-05	105	202	6	24667918
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	SPTBN1 SPIN4 HNRNPL BRCA2 FIG4 PI4KA PRDX3 SHPRH NOP2 FLG EP400 INTS7 APOB NOL9 GSTM2	3.88e-05	754	202	15	35906200
Pubmed	The Nuclear SUMO-Targeted Ubiquitin Quality Control Network Regulates the Dynamics of Cytoplasmic Stress Granules.	SPTBN1 ACTN4 POF1B NOP2 LMO7	3.91e-05	65	202	5	32521226
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GAD2 SPTBN1 SNRK ACTN4 RTN1 MAPK8IP3 NEO1 NDUFA12 PI4KA NAV3 SIPA1L2 HSPA9 CACNA1B MAPK8IP1 SEPTIN5 UBR4 NBEA RHEB MICU3	4.05e-05	1139	202	19	36417873
Pubmed	MRG15 is a novel PALB2-interacting factor involved in homologous recombination.	BRCA2 EP400 PHF12	4.09e-05	12	202	3	19553677
Pubmed	The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes.	UBE2D2 UBE2D3 UBE2D4	4.09e-05	12	202	3	24211586
Pubmed	Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in mice.	SEMA6A FLT1 VCAN PLXNA4	5.02e-05	35	202	4	28172500
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DCAF8 SPTB BLNK ADARB1 HNRNPL MAPK8IP3 TYK2 ABCC8 PVR SHPRH PIP5K1A ASTN2 SEMA6A TET3 MAML3 MGRN1 SEPTIN5 CALCOCO1 FNBP4 JMJD1C ZFHX2 PRORP	6.04e-05	1489	202	22	28611215
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CYP1B1 CHD1 SQOR RFTN1 NDUFA12 PI4KA RRP7A TAF1L CERS2 EP400 SEPTIN5 INTS7 PHF12 DDX51 NOL9 ASH2L ORC4 RSBN1 GPBP1L1 EIF4E DDX20 AQR	6.53e-05	1497	202	22	31527615
Pubmed	Divergent self-association properties of paralogous proteins TRIM2 and TRIM3 regulate their E3 ligase activity.	UBE2D2 UBE2D3 UBE2D4	6.70e-05	14	202	3	36481767
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SQOR DDB1 DDOST HNRNPL CDC40 RRP7A NOP2 TAF1L TET3 HSPA9 CERS2 EP400 INTS7 PHF12 FNBP4 DDX51 NOL9 ASH2L JMJD1C LMO7	7.24e-05	1294	202	20	30804502
Pubmed	Mammalian DET1 regulates Cul4A activity and forms stable complexes with E2 ubiquitin-conjugating enzymes.	DDB1 UBE2D2 UBE2D3	8.34e-05	15	202	3	17452440
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	ZNF280D CHD1 HNRNPL HSPA9 PHF12 ORC4	9.01e-05	124	202	6	20850016
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	CHD1 DDOST HNRNPL UBE2D3 CDC40 RRP7A NOP2 HSPA9 CA1 EP400 UBR4 NOL9 USP16 RHEB FAM83H ORC4 RSBN1 MEPCE DDX20 AQR	9.29e-05	1318	202	20	30463901
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SPTB SPTBN1 ACTN4 DDB1 RTN1 MAPK8IP3 NDUFA12 PI4KA SIPA1L2 DNAH6 HSPA9 MAPK8IP1 SEPTIN5 TNC CALCOCO1 NBEA LMO7 VCAN EIF4E PLXNA4 TRAPPC10	9.85e-05	1431	202	21	37142655
Pubmed	A new spectrin, beta IV, has a major truncated isoform that associates with promyelocytic leukemia protein nuclear bodies and the nuclear matrix.	SPTB SPTBN1	1.00e-04	3	202	2	11294830
Pubmed	Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers.	SEMA6A PLXNA4	1.00e-04	3	202	2	17296555
Pubmed	Molecular linkage of the Ly-3 and Ly-2 genes. Requirement of Ly-2 for Ly-3 surface expression.	CD8B CD8B2	1.00e-04	3	202	2	3258885
Pubmed	Ly-36: a new mouse lymphocyte alloantigen defined by a Mus musculus molossinus-specific monoclonal antibody and controlled by a gene linked to Ly-2/3 region on chromosome 6.	CD8B CD8B2	1.00e-04	3	202	2	3378837
Pubmed	Evidence for close linkage of a mouse light chain marker with the Ly-2,3 locus.	CD8B CD8B2	1.00e-04	3	202	2	100557
Pubmed	Distribution of dystroglycan in normal adult mouse tissues.	ITGA6 LAMA2	1.00e-04	3	202	2	9524190
Pubmed	Interaction of the nuclear matrix-associated region (MAR)-binding proteins, SATB1 and CDP/Cux, with a MAR element (L2a) in an upstream regulatory region of the mouse CD8a gene.	CD8B CD8B2	1.00e-04	3	202	2	9218488
Pubmed	MUL1-RING recruits the substrate, p53-TAD as a complex with UBE2D2-UB conjugate.	UBE2D2 MUL1	1.00e-04	3	202	2	35048531
Pubmed	Sequential dynein effectors regulate axonal autophagosome motility in a maturation-dependent pathway.	MAPK8IP3 MAPK8IP1	1.00e-04	3	202	2	34014261
Pubmed	Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells.	CD8B CD8B2	1.00e-04	3	202	2	12810689
Pubmed	Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.	SEMA6A PLXNA4	1.00e-04	3	202	2	22777942
Pubmed	A CD8 genomic fragment that directs subset-specific expression of CD8 in transgenic mice.	CD8B CD8B2	1.00e-04	3	202	2	9126989
Pubmed	CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation.	CD8B CD8B2	1.00e-04	3	202	2	11754824
Pubmed	Differential expression of laminin isoforms and alpha 6-beta 4 integrin subunits in the developing human and mouse intestine.	ITGA6 LAMA2	1.00e-04	3	202	2	7803849
Pubmed	The synthesis and processing of beta-glucuronidase in normal and egasyn deficient mouse kidney.	CD8B CD8B2	1.00e-04	3	202	2	7236294
Pubmed	An essential role for the stalk region of CD8 beta in the coreceptor function of CD8.	CD8B CD8B2	1.00e-04	3	202	2	19109142
Pubmed	Recombination between kappa chain genetic markers in the mouse.	CD8B CD8B2	1.00e-04	3	202	2	6437974
Pubmed	Reduced thymic maturation but normal effector function of CD8+ T cells in CD8 beta gene-targeted mice.	CD8B CD8B2	1.00e-04	3	202	2	8064243
Interaction	ARK2C interactions	HNRNPL UBE2D2 UBE2D3 UBE2D4	4.21e-06	12	198	4	int:ARK2C
GeneFamily	Fibronectin type III domain containing	NEO1 ASTN2 TRIM36 USH2A CNTFR CDON TNC FSD2 CNTN3	3.21e-06	160	135	9	555
GeneFamily	Immunoglobulin like domain containing	CADM4 NEO1 PVR CNTFR CDON FLT1 BTLA CNTN3	1.02e-04	193	135	8	594
GeneFamily	Adenosine receptors\|V-set domain containing	PSG2 CADM4 SIRPG PVR CD8B SIGLEC6 VCAN	2.24e-04	163	135	7	590
GeneFamily	EF-hand domain containing\|Spectrins	SPTB SPTBN1	1.13e-03	7	135	2	1113
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 NBEA	1.93e-03	9	135	2	1230
Coexpression	PARENT_MTOR_SIGNALING_UP	SAMD9 GBF1 CYP46A1 RTN1 CEP350 CDC40 PI4KA CALCOCO1 LAMA2 CP CPT2 TMBIM6 RHEB VPS13D RESF1 DEPDC5	6.67e-06	567	197	16	M16909
Coexpression	GSE13306_TREG_VS_TCONV_UP	BLNK RUSC2 ASTN2 UPK2 USH2A CNTFR CACNA1B GSTM2 RESF1	2.01e-05	198	197	9	M3229
Coexpression	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN	ACTN4 DDB1 HNRNPL FREM2 FAT1 KCNH1 VASP CACNA1B GSTM2	2.18e-05	200	197	9	M7350
Coexpression	DELACROIX_RAR_TARGETS_UP	BLNK TYK2 NID1 CP RESF1	2.71e-05	47	197	5	M2464
Coexpression	DELACROIX_RAR_TARGETS_UP	BLNK TYK2 NID1 CP RESF1	3.32e-05	49	197	5	MM1078
Coexpression	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	CYP1B1 UBE2D2 NID1 C3 TNC LMO7 VCAN	3.73e-05	121	197	7	M12828
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 FAT1 MAST4 LIPH CA1 DPP10 CP NBEA LMO7 CNTN3 RP1	7.38e-11	191	200	12	23776c7302cead3881b39127398f3b3e0d27885e
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 FAT1 MAST4 LIPH CA1 DPP10 CP NBEA PLXNA4 CNTN3	6.23e-10	180	200	11	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 FREM2 FAT1 MAST4 LIPH CFAP221 LMO7 CNTN3 RP1	1.18e-08	184	200	10	102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	CAPN13 FAT1 MAST4 CDON DPP10 CP NBEA CUBN PLXNA4 CNTN3	1.37e-08	187	200	10	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 RTN1 CAPN13 FAT1 C3 COL4A6 TNC CP GSTM2 TENM3	1.52e-08	189	200	10	319e42f6e2322208de78bc666fb2c074707eb4da
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 FAT1 MAST4 LIPH DPP10 CP NBEA PLXNA4 CNTN3	1.60e-08	190	200	10	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 FAT1 MAST4 LIPH CP NBEA LMO7 CNTN3 RP1	1.85e-08	193	200	10	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	SPTBN1 PERP MAST4 LIPH CFAP221 DNAH6 NBEA DNAI1 LMO7 RP1	2.04e-08	195	200	10	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	SPTBN1 PERP MAST4 LIPH CFAP221 DNAH6 NBEA DNAI1 LMO7 RP1	2.04e-08	195	200	10	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2B6 FAT1 MAST4 LIPH DPP10 CP NBEA LMO7 CNTN3 RP1	2.04e-08	195	200	10	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 FAT1 LIPH CP NBEA LMO7 CNTN3 RP1	1.44e-07	182	200	9	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 RTN1 CAPN13 FAT1 C3 COL4A6 TNC CP TENM3	2.08e-07	190	200	9	050d6e0546954675b6adbfecb67854b1e09739d1
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	CYP1B1 RFTN1 FAT1 TNC CP TMBIM6 GSTM2 RESF1 LMO7	2.17e-07	191	200	9	78ad7c555409ce1391bce406bc0f3ef575329ece
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ACP5 PEX12 FAT1 PVR C3 DNAH6 CDON MGRN1 CP	2.82e-07	197	200	9	6b6504c47c309bac4f790e2f372d454bbdea49e8
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2B6 CAPN13 FAT1 MAST4 LIPH CP LMO7 CNTN3 RP1	2.94e-07	198	200	9	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	CYP1B1 RFTN1 NAV3 NID1 TNC LAMA2 MSRB3 TENM3 VCAN	2.94e-07	198	200	9	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	343B-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CADM4 BLNK NME8 SIRPG ZNF596 P2RX1 SIGLEC6 PLXNA4	1.00e-06	169	200	8	632aa3ab39ec87bafcefec6cddf71129a054d3b0
ToppCell	343B-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	CADM4 BLNK SIRPG ZNF596 CALCOCO1 P2RX1 SIGLEC6 PLXNA4	1.30e-06	175	200	8	b30589ff9dc18e745afe61f289e6d576c9c6c6b2
ToppCell	TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3\|TCGA-Cervix / Sample_Type by Project: Shred V9	CEP350 MAST4 UBR4 PAPOLG VPS13D FRRS1 NIPAL2	1.34e-06	122	200	7	1ed865f0ecfe304fb86313ff51c04e9052357270
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122\|Adult / Lineage, Cell type, age group and donor	CYP2B6 FAT1 LIPH CFAP221 CA1 CP LMO7 RP1	1.36e-06	176	200	8	3fee8a367bb9755aca1b7fcc968b08e51b6e9436
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 FAT1 NEO1 PGLYRP4 CP PLXNA4 CNTN3	1.42e-06	177	200	8	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RFTN1 C3 SIPA1L2 TNC CP MSRB3 TENM3 VCAN	1.54e-06	179	200	8	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 RFTN1 FAT1 NAV3 SIPA1L2 TNC TENM3 VCAN	1.68e-06	181	200	8	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 RFTN1 FAT1 NAV3 SIPA1L2 TNC TENM3 VCAN	1.68e-06	181	200	8	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CADM4 BLNK CYP46A1 NME8 KCTD19 MSRB3 SIGLEC6 PLXNA4	1.75e-06	182	200	8	9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CADM4 BLNK CYP46A1 NME8 KCTD19 MSRB3 SIGLEC6 PLXNA4	1.75e-06	182	200	8	4602a98df7045e2c70b7560abfba9b444fbd5d30
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	CYP2B6 CAPN13 MAST4 LIPH DPP10 CP LMO7 RP1	1.98e-06	185	200	8	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	15-Distal-Epithelial-Secretory_progenitor\|Distal / Age, Tissue, Lineage and Cell class	PERP FREM2 LIPH UPK2 TRIM36 CP LMO7 RP1	2.23e-06	188	200	8	9a64fb07de611de38d6f24673feb3b81a5e85384
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 NAV3 NID1 CDON LAMA2 MSRB3 TENM3 VCAN	2.60e-06	192	200	8	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 NID1 C3 LOXL3 CNTFR CDON LAMA2 VCAN	2.60e-06	192	200	8	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 CHD1 NID1 C3 CNTFR LAMA2 JMJD1C VCAN	2.60e-06	192	200	8	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 NID1 C3 LOXL3 CNTFR CDON LAMA2 VCAN	2.60e-06	192	200	8	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 NAV3 C3 CNTFR CDON LAMA2 CP MSRB3	2.92e-06	195	200	8	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	SPTBN1 PERP MAST4 CFAP221 DNAH6 DNAI1 LMO7 RP1	3.03e-06	196	200	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 FAT1 NAV3 NID1 C3 LAMA2 CP TENM3	3.03e-06	196	200	8	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 FAT1 NAV3 NID1 C3 LAMA2 CP TENM3	3.03e-06	196	200	8	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Club\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CYP2B6 PERP FREM2 LIPH C3 UPK2 CP LMO7	3.03e-06	196	200	8	4e4c632db73b1340d80bf40a7657cb4821084d3c
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	SPTBN1 PERP MAST4 CFAP221 DNAH6 DNAI1 LMO7 RP1	3.03e-06	196	200	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	distal-Hematologic-Plasmacytoid_Dendritic-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BLNK CYP46A1 NME8 DCANP1 MED12L KCTD19 BTLA PLXNA4	3.15e-06	197	200	8	3a5908deb5c5a2bf06019a102fb1652233cf2a2a
ToppCell	severe-dn_T\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ACP5 SPTBN1 ELP6 SIRPG FAT1 NDUFA12 IBTK CD8B	3.27e-06	198	200	8	d4f2213af45ada47e6c62675f468ce05692db507
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	POF1B CAPN13 DPP10 CP NBEA GSDMC CNTN3 IFNE	3.27e-06	198	200	8	af07a970afaa435c6433bb5c1cbff4c67af350c7
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2B6 CAPN13 MAST4 LIPH CP LMO7 CNTN3 RP1	3.27e-06	198	200	8	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 C3 SIPA1L2 FLG TNC TENM3 VCAN	3.40e-06	199	200	8	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CYP1B1 ADARB1 NID1 TNC CP TENM3 VCAN PLXNA4	3.40e-06	199	200	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 FAT1 C3 SIPA1L2 FLG TNC TENM3 VCAN	3.40e-06	199	200	8	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	control-unassigned\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZNF280D ITGA6 RFTN1 NEO1 POC1B CALCOCO1 LMO7 NIPAL2	3.40e-06	199	200	8	5db7c8089172ac8e796613b3cef618d87007a0ab
ToppCell	LPS_anti-TNF-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TRPM6 CMBL FIG4 LIPH POC1B PGBD5 P2RX1 PRORP	3.52e-06	200	200	8	0b02f3ca3d8612ed7af46381195b0ed5591313cf
ToppCell	Bronchus_Control_(B.)-Epithelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	PERP ITGA6 CAPN13 MAST4 TNC CP NBEA LMO7	3.52e-06	200	200	8	f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCell	356C-Myeloid-Mast_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	SPTB MED12L PGBD5 NBEA IDS P2RX1 SIGLEC6	4.86e-06	148	200	7	1668d8a9e680da335362744f36b05446c499347e
ToppCell	356C-Myeloid-Mast_cell-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SPTB MED12L PGBD5 NBEA IDS P2RX1 SIGLEC6	4.86e-06	148	200	7	18511ba10765eda937c5a710626361f7e6b9b321
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USH2A CACNA1B KCTD19 LAMA2 TEAD4 PKHD1L1 CNTN3	8.11e-06	160	200	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USH2A CACNA1B KCTD19 LAMA2 TEAD4 PKHD1L1 CNTN3	8.11e-06	160	200	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1\|E16.5-samps / Age Group, Lineage, Cell class and subclass	GAD2 SQOR ADARB1 FSD2 CP GSTM2 CD8B	9.15e-06	163	200	7	f1ec2625b52664308968b01d8e0275e1e0751480
ToppCell	10x5'-Liver-Myeloid_Dendritic-pDC\|Liver / Manually curated celltypes from each tissue	CADM4 BLNK CYP46A1 KCTD19 MSRB3 P2RX1 SIGLEC6	1.03e-05	166	200	7	24dfa9f3e0842f9ab8350bf6a52ae0d10f2a0c44
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 NAV3 C3 CNTFR LAMA2 MSRB3 VCAN	1.11e-05	168	200	7	4b2d29a7843bf45922038c093ca7ec0600756adc
ToppCell	10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC\|lymph-node_spleen / Manually curated celltypes from each tissue	CADM4 CYP46A1 NME8 KCTD19 MSRB3 P2RX1 SIGLEC6	1.11e-05	168	200	7	cfed36fece51871a5abbcde71f6bd5e7212357ff
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NID1 CNTFR LAMA2 MSRB3 TENM3 VCAN PLXNA4	1.16e-05	169	200	7	a84490724a206c9bbb145f7ce08613f91d100ac4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 NAV3 C3 CNTFR LAMA2 MSRB3 VCAN	1.25e-05	171	200	7	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NT5C3A SPTB ITGA6 ABCB4 MED12L PKD1L3 P2RX1	1.30e-05	172	200	7	e39ea2f4edbf36ebf9604fa6f9349081859c596c
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	ADARB1 RFTN1 C3 SIPA1L2 TNC TENM3 VCAN	1.30e-05	172	200	7	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NT5C3A SPTB ITGA6 ABCB4 MED12L PKD1L3 P2RX1	1.30e-05	172	200	7	875ea290840e835952623b905eb610f3c71456d2
ToppCell	PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NT5C3A SPTB ITGA6 ABCB4 MED12L PKD1L3 P2RX1	1.30e-05	172	200	7	bcc50bed47465daa953ba91f17d1ee4c947ab461
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAD2 SNRK MAST4 NID1 SEMA6A FLT1 MSRB3	1.30e-05	172	200	7	a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	CAPN13 CA1 CDON PGLYRP4 CP NBEA CNTN3	1.40e-05	174	200	7	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAD2 SNRK MAST4 NID1 SEMA6A FLT1 MSRB3	1.51e-05	176	200	7	3494ffa8555e6edf4b1250e10434bae9b73ec845
ToppCell	droplet-Liver-Npc-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAD2 SNRK MAST4 NID1 SEMA6A FLT1 MSRB3	1.51e-05	176	200	7	d43f6b7828b98e1dab7b726a5f99499d65a7db80
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CAPN13 MAST4 LIPH CFAP221 DPP10 CP NBEA	1.51e-05	176	200	7	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH1 NAV3 NID1 C3 CNTFR LAMA2 VCAN	1.56e-05	177	200	7	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NID1 TNFSF15 CDON TNC LAMA2 NBEA VCAN	1.56e-05	177	200	7	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCNH1 NAV3 NID1 C3 CNTFR LAMA2 VCAN	1.56e-05	177	200	7	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	CYP2B6 CAPN13 MAST4 LIPH CA1 CP CNTN3	1.62e-05	178	200	7	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 UPK2 TNC CP GSTM2 TENM3 CNTN3	1.74e-05	180	200	7	35c73670da90cb6924e822a2426d13a675685f09
ToppCell	NS-moderate-d_16-33-Myeloid-pDC\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BLNK CYP46A1 NME8 RFTN1 MSRB3 P2RX1 PLXNA4	1.74e-05	180	200	7	144818e69613296cde43f29cb8c20899c670b319
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF280D PERP DNAH6 LAMA2 CD8B P2RX1 LMO7	1.81e-05	181	200	7	41969fe4d94ee77b12ecde32170aaf0b13e49644
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAV3 NID1 CNTFR HTR2B TNC LAMA2 VCAN	1.81e-05	181	200	7	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF280D PERP DNAH6 LAMA2 CD8B P2RX1 LMO7	1.81e-05	181	200	7	3f50e61dc2a52d71a5801584617607e6246adcf2
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NAV3 NID1 CNTFR HTR2B TNC LAMA2 VCAN	1.81e-05	181	200	7	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Colonocyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PERP SQOR POF1B LIPH CA1 CUBN P2RX1	1.81e-05	181	200	7	bec917f6f56ae252639a5a76024be5df5c70a6d5
ToppCell	11.5-Distal-Immune-Immune\|Distal / Age, Tissue, Lineage and Cell class	BLNK RTN1 NME8 SIRPG KYNU BTLA SIGLEC6	1.81e-05	181	200	7	193ee02f547a218b2fc13e1174ea4cff4f8a3450
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	CYP2B6 FREM2 MAST4 CDON CP LMO7 RP1	1.81e-05	181	200	7	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPTBN1 LINC01558 NAV3 NID1 SEMA6A PKHD1L1 TENM3	1.94e-05	183	200	7	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PERP ITGA6 FAT1 COL4A6 DPP10 TNC FAM83H	1.94e-05	183	200	7	bbf27d2f4369031fadacacd6c432c06b1ec5abdb
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP1B1 ZNF280D C3 MAPK8IP1 MARVELD1 LAMA2 PLXNA4	1.94e-05	183	200	7	269afec240a756eec3bbae5f30ec784281af3433
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPIN4 NID1 LOXL3 CNTFR MAPK8IP1 SEPTIN5 VCAN	2.01e-05	184	200	7	d754c3de621429b220ae4ac426cdfc619e848462
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Adult / Lineage, Cell type, age group and donor	CYP2B6 FAT1 MAST4 LIPH CFAP221 CP LMO7	2.08e-05	185	200	7	673f0c688ae6984bc8027df2da335787924f4137
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2B6 FAT1 MAST4 LIPH CA1 LMO7 RP1	2.08e-05	185	200	7	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYP1B1 C15orf39 RUSC2 FLT1 ZBTB47 P2RX1 VCAN	2.08e-05	185	200	7	68edb1bb03ed221d49e583123ca4de14252d7bc5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 FAT1 SIPA1L2 MAML3 COL4A6 MSRB3 TENM3	2.08e-05	185	200	7	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	BAL-Mild-Myeloid-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BLNK NME8 KCTD19 MSRB3 P2RX1 SIGLEC6 PLXNA4	2.08e-05	185	200	7	c2e70405969616c28fb6379ee318e17bbcef7b49
ToppCell	BAL-Mild-Myeloid-pDC-pDC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BLNK NME8 KCTD19 MSRB3 P2RX1 SIGLEC6 PLXNA4	2.08e-05	185	200	7	f4588468e8654363f48adbe427dff10f16f1c7fe
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RFTN1 FAT1 SIPA1L2 MAML3 COL4A6 MSRB3 TENM3	2.08e-05	185	200	7	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	BAL-Mild-Myeloid-pDC-pDC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BLNK NME8 KCTD19 MSRB3 P2RX1 SIGLEC6 PLXNA4	2.08e-05	185	200	7	3cb816fc9541c04b4436e21d984216cfbbacff98
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PERP ADARB1 HNRNPL UBE2D3 PVR CP JMJD1C	2.08e-05	185	200	7	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CYP2B6 FREM2 MAST4 LIPH CFAP221 LMO7 RP1	2.15e-05	186	200	7	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	PERP CAPN13 FAT1 MAST4 LIPH CP LMO7	2.15e-05	186	200	7	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NT5C3A SPTB POC1B MED12L CA1 COL4A6 PKHD1L1	2.15e-05	186	200	7	e5014443e9d6e25943308483e20d48b776ae5373
ToppCell	LPS_only-Hematopoietic_Meg-Ery-Erythroid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NT5C3A SPTB POC1B MED12L CA1 COL4A6 PKHD1L1	2.15e-05	186	200	7	affc246a1091e44dc85a5e237c778a7541d5a2b4
ToppCell	LPS_only-Hematopoietic_Meg-Ery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NT5C3A SPTB POC1B MED12L CA1 COL4A6 PKHD1L1	2.15e-05	186	200	7	40d1e15402fdfb3b5ae850a2070cd4b68fda3159
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 C15orf39 NAV3 SEMA6A HTR2B CP NBEA	2.15e-05	186	200	7	0de87109da9324c597fadf2eb782f0f158afe832
ToppCell	droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 C15orf39 NAV3 SEMA6A HTR2B CP NBEA	2.15e-05	186	200	7	f23f21781a758541f59c06efa7739d26a03fb478
Disease	gamma-glutamylmethionine measurement	ASTN2 MAML3 CACNA1B	1.01e-05	7	197	3	EFO_0021141
Disease	Disorder of eye	CYP1B1 MAK FREM2 CC2D2A USH2A BBS5 WDPCP VCAN RP1	1.37e-05	212	197	9	C0015397
Disease	gastroesophageal reflux disease	SNRK ADARB1 NAV3 MAML3 APOB VCAN	6.14e-05	101	197	6	EFO_0003948
Disease	subiculum volume	SPTBN1 ASTN2 MSRB3 VCAN	1.94e-04	43	197	4	EFO_0009399
Disease	spinocerebellar ataxia type 5 (implicated_via_orthology)	SPTB SPTBN1	2.64e-04	4	197	2	DOID:0050882 (implicated_via_orthology)
Disease	cholesteryl esters to total lipids in IDL percentage	GCKR CERS2 APOB JMJD1C	3.49e-04	50	197	4	EFO_0022247
Disease	gamma-glutamylglutamine measurement	UBE2D3 ASTN2 MAML3	4.11e-04	22	197	3	EFO_0021138
Disease	phospholipids in medium HDL measurement	GCKR CERS2 APOB GSTM2	5.04e-04	55	197	4	EFO_0022295
Disease	total lipids in medium HDL measurement	GCKR CERS2 APOB GSTM2	6.17e-04	58	197	4	EFO_0022310
Disease	free cholesterol in medium HDL measurement	GCKR CERS2 APOB GSTM2	6.17e-04	58	197	4	EFO_0022267
Disease	milk allergy measurement, parental genotype effect measurement	MGRN1 RNASE11	6.54e-04	6	197	2	EFO_0005939, EFO_0007019
Disease	brain edema (implicated_via_orthology)	ABCC8 CP	6.54e-04	6	197	2	DOID:4724 (implicated_via_orthology)
Disease	cholesterol in medium HDL measurement	GCKR CERS2 APOB GSTM2	6.58e-04	59	197	4	EFO_0021903
Disease	epilepsy (implicated_via_orthology)	GAD2 ITGA6 KCNH1 CACNA1B COX7A2P2 DEPDC5	8.18e-04	163	197	6	DOID:1826 (implicated_via_orthology)
Disease	neuroimaging measurement	SAMD9 NBEAL1 SPTBN1 ACTN4 MAPK8IP3 TYK2 NEO1 MAST4 NAV3 CC2D2A C2orf76 COX7A2P2 LAMA2 JMJD1C MSRB3 VCAN NIPAL2	8.76e-04	1069	197	17	EFO_0004346
Disease	chronic mucus hypersecretion	USH2A MAML3	9.11e-04	7	197	2	EFO_0005673
Disease	beta-citrylglutamate measurement	HTR3D JMJD1C	9.11e-04	7	197	2	EFO_0800060
Disease	LDL cholesterol change measurement	APOB PKD1L3	9.11e-04	7	197	2	EFO_0007804
Disease	coronary artery disease, factor VII measurement	NBEAL1 GCKR FCHO1 FLT1 APOB	9.12e-04	111	197	5	EFO_0001645, EFO_0004619
Disease	factor VIII measurement, coronary artery disease	NBEAL1 FCHO1 FLT1 APOB RP1	9.88e-04	113	197	5	EFO_0001645, EFO_0004630
Disease	cholesteryl esters to total lipids in large LDL percentage	GCKR APOB JMJD1C	1.15e-03	31	197	3	EFO_0022249
Disease	total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer	GCKR MAML3 APOB TEAD4	1.19e-03	69	197	4	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Disease	granule cell layer dentate gyrus volume	ASTN2 MSRB3	1.21e-03	8	197	2	EFO_0009403
Disease	tissue plasminogen activator measurement, coronary artery disease	NBEAL1 FCHO1 FLT1 APOB	1.32e-03	71	197	4	EFO_0001645, EFO_0004791
Disease	mean platelet volume	SPTBN1 ITGA6 ACTN4 GCKR SIRPG DCANP1 MAST4 PI4KA PVR NID1 HTR3D KYNU JMJD1C GSTM2 RSBN1 P2RX1	1.43e-03	1020	197	16	EFO_0004584
Disease	melanoma	CYP1B1 BRCA2 FLT1 TNC UBR4 CP CUBN	1.45e-03	248	197	7	C0025202
Disease	hippocampus molecular layer volume	ASTN2 MSRB3 VCAN	1.64e-03	35	197	3	EFO_0009397
Disease	total lipids in small HDL measurement	GCKR CERS2 GSTM2	1.64e-03	35	197	3	EFO_0022311
Disease	apolipoprotein B measurement	GCKR ZNF235 ABCB4 YIPF2 BRCA2 FIG4 PVR VASP APOB PKD1L3 GSTM2 RP1	1.76e-03	663	197	12	EFO_0004615
Disease	cholesterol in small HDL measurement	GCKR CERS2 GSTM2	1.78e-03	36	197	3	EFO_0022226
Disease	level of Triacylglycerol (51:3) in blood serum	GCKR APOB	1.93e-03	10	197	2	OBA_2045163
Disease	Global developmental delay	MAPK8IP3 ALKBH8 TET3 CACNA1B NBEA	2.03e-03	133	197	5	C0557874
Disease	phospholipids in small HDL measurement	GCKR CERS2 GSTM2	2.08e-03	38	197	3	EFO_0022296
Disease	dentate gyrus volume measurement	MAST4 ASTN2 MSRB3	2.24e-03	39	197	3	EFO_0010083
Disease	Neurodegenerative Disorders	KYNU SEPTIN5 GSTM2	2.24e-03	39	197	3	C0524851
Disease	Degenerative Diseases, Central Nervous System	KYNU SEPTIN5 GSTM2	2.24e-03	39	197	3	C0270715
Disease	degree of unsaturation measurement	GCKR APOB JMJD1C	2.24e-03	39	197	3	EFO_0022261
Disease	Degenerative Diseases, Spinal Cord	KYNU SEPTIN5 GSTM2	2.24e-03	39	197	3	C0751733
Disease	functional brain measurement	POC1B CC2D2A MSRB3 VCAN	2.25e-03	82	197	4	EFO_0007849
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	GCKR APOB	2.34e-03	11	197	2	OBA_2045170
Disease	hippocampal amigdala transition area volume	ASTN2 MSRB3	2.34e-03	11	197	2	EFO_0009401
Disease	hippocampal CA4 volume	MAST4 ASTN2 MSRB3	2.59e-03	41	197	3	EFO_0009396
Disease	quality of life during menstruation measurement, decreased attention	TRIM36 MAML3	2.80e-03	12	197	2	EFO_0009366, NCIT_C117245
Disease	Colorectal Carcinoma	CYP1B1 CHD1 ABCB4 FAT1 ABCC8 NID1 FAM110B COL4A6 APOB CUBN RHEB LMO7	2.81e-03	702	197	12	C0009402
Disease	mean reticulocyte volume	SAMD9 NT5C3A SPTB C15orf39 CHD1 GCKR ABCB4 CEP350 CC2D2A CA1 EP400 JMJD1C RESF1	2.90e-03	799	197	13	EFO_0010701
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	BLNK SNRK POC1B SIPA1L2 USH2A TET3 MAML3 COX7A2P2 LAMA2 NBEA WDPCP PLXNA4 CNTN3	2.96e-03	801	197	13	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Brittle diabetes	TYK2 ABCC8 CP	3.17e-03	44	197	3	C0342302
Disease	Diabetes Mellitus, Sudden-Onset	TYK2 ABCC8 CP	3.17e-03	44	197	3	C4554117
Disease	Diabetes, Autoimmune	TYK2 ABCC8 CP	3.17e-03	44	197	3	C0205734
Disease	Diabetes Mellitus, Ketosis-Prone	TYK2 ABCC8 CP	3.17e-03	44	197	3	C3837958
Disease	Granulomatosis with Polyangiitis	SEMA6A TENM3	3.30e-03	13	197	2	EFO_0005297
Disease	obesity (implicated_via_orthology)	ADARB1 TYK2 MED12L C3 GSTM2 ZFHX2	3.32e-03	215	197	6	DOID:9970 (implicated_via_orthology)
Disease	Diabetes Mellitus, Insulin-Dependent	TYK2 ABCC8 CP	3.38e-03	45	197	3	C0011854
Disease	cholesterol to total lipids in large VLDL percentage	GCKR APOB JMJD1C	3.38e-03	45	197	3	EFO_0022236
Disease	cortical thickness	NBEAL1 SPTBN1 ACTN4 MAPK8IP3 NEO1 MAST4 PI4KA NAV3 ASTN2 TRIM36 COX7A2P2 LAMA2 FSD2 JMJD1C VPS13D VCAN	3.39e-03	1113	197	16	EFO_0004840
Disease	eye morphology measurement	ABCB4 NAV3 ASTN2 FAM110B GSTM2 RP1	3.55e-03	218	197	6	EFO_0007858
Disease	Seizures	GAD2 ALKBH8 MED12L TET3 CACNA1B NBEA	3.55e-03	218	197	6	C0036572
Disease	triacylglycerol 54:4 measurement	ITGA6 GCKR APOB	3.60e-03	46	197	3	EFO_0010422
Disease	autism spectrum disorder (implicated_via_orthology)	ZNF280D CHD1 HTR2B NBEA EIF4E	3.61e-03	152	197	5	DOID:0060041 (implicated_via_orthology)
Disease	vascular dementia (biomarker_via_orthology)	FLT1 EIF4E	3.83e-03	14	197	2	DOID:8725 (biomarker_via_orthology)
Disease	colonic neoplasm, overall survival	DPP10 IDS	3.83e-03	14	197	2	EFO_0000638, EFO_0004288
Disease	Primary biliary cirrhosis	ABCB4 TYK2 TNFSF15	3.83e-03	47	197	3	C0008312
Disease	frontal fibrosing alopecia	CYP1B1 NDUFA12 CNTN3	4.06e-03	48	197	3	EFO_0009855
Disease	hippocampal CA1 volume	ASTN2 MSRB3 VCAN	4.06e-03	48	197	3	EFO_0009394
Disease	cholesteryl esters to total lipids in small VLDL percentage	GCKR APOB JMJD1C	4.31e-03	49	197	3	EFO_0022256
Disease	employment status	SQOR PLXNA4	4.40e-03	15	197	2	EFO_0005241
Disease	Meckel-Gruber syndrome	CC2D2A WDPCP	4.40e-03	15	197	2	C0265215
Disease	liver volume	GCKR JMJD1C	4.40e-03	15	197	2	EFO_0600048
Disease	triacylglycerol 52:3 measurement	GCKR APOB	4.40e-03	15	197	2	EFO_0010415
Disease	Hypertriglyceridemia	GCKR APOB	4.40e-03	15	197	2	C0020557
Disease	cognitive inhibition measurement	TRPM6 USH2A MSRB3	4.56e-03	50	197	3	EFO_0007969
Disease	triglycerides to total lipids in medium LDL percentage	GCKR APOB JMJD1C	4.56e-03	50	197	3	EFO_0022334
Disease	polyunsaturated fatty acids to total fatty acids percentage	GCKR APOB JMJD1C	4.56e-03	50	197	3	EFO_0022303
Disease	Adenoid Cystic Carcinoma	FAT1 MAML3 JMJD1C VCAN	4.59e-03	100	197	4	C0010606
Disease	triglycerides to total lipids in large LDL percentage	GCKR APOB JMJD1C	4.82e-03	51	197	3	EFO_0022331
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	GCKR APOB JMJD1C	4.82e-03	51	197	3	EFO_0022302
Disease	Intrahepatic cholestasis of pregnancy	GCKR ABCB4	5.00e-03	16	197	2	EFO_0009048
Disease	Pre-Eclampsia	FLT1 CP	5.00e-03	16	197	2	C0032914
Disease	myopia (is_implicated_in)	LOXL3 LAMA2	5.00e-03	16	197	2	DOID:11830 (is_implicated_in)
Disease	Alpha ketoglutarate measurement	SAMD9 TENM3	5.00e-03	16	197	2	EFO_0010457
Disease	sickle cell anemia (is_implicated_in)	C3 APOB	5.00e-03	16	197	2	DOID:10923 (is_implicated_in)
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	GCKR CERS2 APOB JMJD1C	5.09e-03	103	197	4	EFO_0008595, EFO_0020944
Disease	Disease Exacerbation	DDB1 HNRNPL ABCB4 PRDX3 FLT1	5.11e-03	165	197	5	C0235874
Disease	triglycerides to total lipids in very large VLDL percentage	GCKR APOB JMJD1C	5.37e-03	53	197	3	EFO_0022340
Disease	response to cisplatin, platinum measurement	ADARB1 INTS7 TENM3	5.37e-03	53	197	3	EFO_0010154, GO_0072718
Disease	free cholesterol to total lipids in small LDL percentage	GCKR APOB JMJD1C	5.37e-03	53	197	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	GCKR APOB JMJD1C	5.37e-03	53	197	3	EFO_0022258
Disease	platelet measurement	ACTN4 GCKR SIRPG MED12L SEPTIN5 JMJD1C P2RX1	5.42e-03	315	197	7	EFO_0005036
Disease	lipoprotein measurement	GCKR CERS2 APOB GSTM2	5.45e-03	105	197	4	EFO_0004732
Disease	Bardet-Biedl syndrome 1 (disorder)	BBS5 WDPCP	5.65e-03	17	197	2	C2936862
Disease	Kuhnt-Junius degeneration (is_implicated_in)	C3 FLT1	5.65e-03	17	197	2	DOID:10873 (is_implicated_in)
Disease	cholesterol to total lipids in very large VLDL percentage	GCKR APOB JMJD1C	5.66e-03	54	197	3	EFO_0022244
Disease	gallstones	GCKR ABCB4 POC1B JMJD1C	6.02e-03	108	197	4	EFO_0004210
Disease	phosphatidylethanolamine measurement	GCKR USH2A COX7A2P2 APOB CNTN3	6.23e-03	173	197	5	EFO_0010228
Disease	triglycerides in large VLDL measurement	GCKR APOB JMJD1C	6.27e-03	56	197	3	EFO_0022178
Disease	triglycerides in very large VLDL measurement	GCKR APOB JMJD1C	6.27e-03	56	197	3	EFO_0022325
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	GCKR APOB JMJD1C	6.27e-03	56	197	3	EFO_0022316
Disease	free cholesterol to total lipids in large HDL percentage	GCKR APOB GSTM2	6.27e-03	56	197	3	EFO_0022279
Disease	cholesteryl esters to total lipids in large VLDL percentage	GCKR APOB JMJD1C	6.27e-03	56	197	3	EFO_0022250
Disease	glucose homeostasis measurement, acute insulin response measurement	ASTN2 MICU3	6.32e-03	18	197	2	EFO_0006831, EFO_0006896

Protein segments in the cluster

Peptide	Gene	Start	Entry
ALKGQEFAPSHQQVY	TNFSF15	71	O95150
GITAAFKPTSQHYTN	ZNF280D	81	Q6N043
QAGVYHPNVKVVSNF	NT5C3A	216	Q9H0P0
NPKHASVLAESGINY	EP400	2491	Q96L91
VSPGNSHLALYQVFK	DCANP1	146	Q8TF63
VSSGVNPLVYTLFNK	HTR2B	371	P41595
NSLHKVYSASPIFGV	BBS5	251	Q8N3I7
VGYTLVKHSQSEQVP	COL4A6	1466	Q14031
VTQHTSFRGYIIPKD	CYP2B6	371	P20813
DVTTTPSVQYINGKH	VCAN	1401	P13611
PSVQYINGKHLVTTV	VCAN	1406	P13611
NKPGIVYASLNHSVI	BTLA	251	Q7Z6A9
SKLPVHVNRTSFYSQ	ALKBH8	576	Q96BT7
LHPVDATSYGKQTNV	APOF	31	Q13790
VPAHKYVLAVGSSVF	BTBD6	151	Q96KE9
TQQFLSGHLPKYEQV	GSDMC	286	Q9BYG8
NHIKLSGSNPYTTVT	ACTN4	601	O43707
PGSTVLYRIFTVNHK	C3	141	P01024
VHYQHVFQKVQTSPG	CAPN13	571	Q6MZZ7
VKFFGPLSSNTLHQV	AQR	366	O60306
HAPQNIVRYSFKEGT	DNAI1	76	Q9UI46
AVHYTQVGNLIPKDS	DNAI1	101	Q9UI46
QSFSHYSIVGQKLGV	ELP6	56	Q0PNE2
HGSVSYNSNPVVFKE	FLG	3996	P20930
KAAVHTYGIASVPNQ	DDX20	456	Q9UHI6
FKPVVYHGVNLDQTV	C2orf76	21	Q3KRA6
ITYKTANSSPIHFAG	CACNA1B	2201	Q00975
GKTIQTISFLNYLFH	CHD1	511	O14646
NATLEHFYLTSGKQP	CERS2	81	Q96G23
HFYLTSGKQPKQVEV	CERS2	86	Q96G23
YQLAVASFPNKGVTS	COX7A2P2	71	O60397
TIKLYVVNLYGPTHT	DPP10	291	Q8N608
QPAIGTKVSDYILQH	ASTN2	1091	O75129
TPHSEIIFYKNGVNQ	ASH2L	536	Q9UBL3
GNIVSPSEIQAHLKY	CPT2	261	P23786
ASKPFQILYGHTNEV	NBEAL1	2481	Q6ZS30
LKFVGVIPQYHSSVN	RFTN1	156	Q14699
TIAIKHYFSIVPGNV	INTS7	321	Q9NVH2
VYSPQQIIKVYVGSH	KCTD19	391	Q17RG1
TNHKFNVTGTPEQYV	NDUFA12	111	Q9UI09
IRVTFHNKGAYPLSI	CP	461	P00450
QSPHSNLFGVQVQYK	ORC4	31	O43929
AENKPQYIHVTGTVF	DEPDC5	1496	O75140
FEVLYHSVKQGPIST	FCHO1	16	O14526
QFSSVKVIHVTSPQF	FAT1	346	Q14517
HLKTATVNFITSYPG	NOL9	226	Q5SY16
IKTGHPRYFNQLSTG	GAD2	171	Q05329
HSPKQDNIISVFYTI	OR2AG2	266	A6NM03
FTHYDILTPNGTKVA	LOXL3	616	P58215
NIVINPSKIGAYFSS	MED12L	61	Q86YW9
VNPNGHTYTFIDKVD	MAGEB2	171	O15479
VNIHYKSPTTAGFSQ	MAPK8IP3	596	Q9UPT6
ILTYGNTKPLTHFNA	MAML3	596	Q96JK9
YELVATPHNTSKGFQ	MEPCE	661	Q7L2J0
HANGNKLSSVVPSVY	GPBP1L1	221	Q9HC44
VTFQVGNRLFPAHKY	IBTK	566	Q9P2D0
QFRVKFLGSVQVPYH	MAPK8IP1	566	Q9UQF2
VHYKRGVSQQFSLPS	MGRN1	161	O60291
KHSVPQSLPQSNYFT	JMJD1C	1081	Q15652
SVEYHSLVSQGKPQS	FREM2	3031	Q5SZK8
PKIVIGYQSHADTAT	EIF4E	191	P06730
HYQVPDGSVVALVSK	PLXNA4	1586	Q9HCM2
VKYTQTFTLHANPAV	PERP	131	Q96FX8
AVQKGHLSSSYVQPL	PGLYRP4	176	Q96LB8
AFQPHKQTRLYGITT	NID1	1186	P14543
AAGKYHFSNLVSPTN	NAV3	1471	Q8IVL0
KVGLYTIYVNPANTH	DCAF8	331	Q5TAQ9
PSDVFKQYSHLTGTQ	GANC	341	Q8TET4
PYLIDGTHKITQSNA	GSTM2	61	P28161
HPLTAQYGVKVLRSF	PI4KA	1631	P42356
KHSFYPIPEQTLQAT	KCNH1	911	O95259
GLETVYEKFHPSIQS	MUL1	151	Q969V5
FVRKTGVFHANPYVL	LMO7	516	Q8WWI1
QSPSIKNGIEYHYVT	LAMA2	111	P24043
EPTTFQKYHQVSLLA	LIPH	366	Q8WWY8
AVYVATGLKFSPHLV	MICU3	461	Q86XE3
VFIYHGSANGINTKP	ITGA6	446	P23229
YVGHKDVVTSVQFSP	POC1B	56	Q8TC44
TQYPHAVGKNTLLIA	DDOST	231	P39656
LKENVQFHLYISTSP	ADARB1	436	P78563
YLGHTAKNAVITVPA	HSPA9	181	P38646
ITYQPSVSGEHKAQV	PIP5K1A	481	Q99755
SHFFPGNNVIYEKTI	POF1B	156	Q8WVV4
PYRNSVQKAHIYGIT	ABCB4	926	P21439
VQKAHIYGITFSISQ	ABCB4	931	P21439
RAHQVTYSQSPKIAT	GCKR	301	Q14397
NTFTKLITVNGQEYH	RHEB	41	Q15382
RSSQTTHGLYKVQPF	PGBD5	221	Q8N414
DSQRQQKHYGITSPI	PAPOLG	11	Q9BWT3
SPTHVGFKAKYSIAQ	CUBN	2321	O60494
FGTKQPYQVFTVEHS	WDPCP	291	O95876
HLRVSTAFVYTKNPN	APOB	3701	P04114
LHGNSVLQQTPAYIK	CD8B2	16	A6NJW9
EQVKYSVPDTGLFQH	LINC01558	36	Q9Y6Z2
DYHKVQSSGSFINTP	DNAH6	396	Q9C0G6
GHDSKQPYTLVVFFN	BLNK	376	Q8WV28
VKPLIDAVYSTGVHN	CC2D2A	1571	Q9P2K1
SLKFHNPDVYTLVTG	CARD14	91	Q9BXL6
PEHLISQKGFSYNVV	BRCA2	2036	P51587
YGPVVRVNVFHKTSV	CYP46A1	71	Q9Y6A2
KQLRAHGISSYFPVQ	DDX51	211	Q8N8A6
SIYSRFVQLGQSQHK	FIG4	816	Q92562
SYNPATAKEIINVGH	CA1	51	P00915
LHGNSVLQQTPAYIK	CD8B	16	P10966
HISYVANYPNGKVTQ	FRRS1	16	Q6ZNA5
EPGSTYKFRVIAINH	CDON	786	Q4KMG0
YIPNTFNVTVLHGSK	CNTFR	136	P26992
LPSGHSKQTQYVLDV	CADM4	206	Q8NFZ8
SPHSVINIFTKSYQL	CEP350	1061	Q5VT06
PSTQQHLKKVYASFA	TMBIM6	21	P55061
SQALKHPYFQVGQVL	MAK	276	P20794
TSKYQGPVHFALFVS	MARVELD1	51	Q9BSK0
PIVIHSSGKNYGFTI	MAST4	1141	O15021
RHSFAESLKVYPTQG	FAM110B	156	Q8TC76
GHPAFVNYSTSQKIS	HNRNPL	166	P14866
KNAFPVSGQLYTTHL	GBF1	561	Q92538
NTSVLGYHIPKDTVV	CYP1B1	406	Q16678
VHAGNFSTIPQYFKE	IDS	111	P22304
QVLHNESKGSPTSAY	FAM83H	861	Q6ZRV2
TTGKQFPRCQYHSVT	RNASE11	161	Q8TAA1
GSPIHTSVQFQASYL	CALCOCO1	76	Q9P1Z2
GKDNHSPVISYSIQA	CNTN3	621	Q9P232
PTVIYSSNHKLVFSN	DDB1	656	Q16531
VVVLNNSKFYHIGTT	FPGT	361	O14772
SLSPQQYQKGHTLAI	IFNE	66	Q86WN2
HTPGQDKFLAIFYTI	OR2AJ1	266	Q8NGZ0
SVTHSFISAGNKVYP	RP1	1866	P56715
VTIKFTPFQYGTAQI	CFAP221	221	Q4G0U5
QPKVGFYSSLNQTHT	FBXL21P	21	Q9UKT6
FIVTPKQTQGYCAEH	P2RX1	106	P51575
AVFHQTQGPSYSESK	PVR	76	P15151
HGLYNKVSQFPELTS	RUSC2	1086	Q8N2Y8
TYFTGILQKENGHVT	RTN1	121	Q16799
YFIPRNVIHQFKTVS	RSBN1	676	Q5VWQ0
LSQKVTHLIPFTNYS	USH2A	2776	O75445
FAHPKIGSNYSVKTV	SQOR	161	Q9Y6N5
TIKAQHEYVGPTTNF	TRIM36	191	Q9NQ86
DKQYVGFATLPNQVH	SEPTIN5	21	Q99719
PVLYSQSAIATGHQA	FNBP4	811	Q8N3X1
YGSQPLQSTQHITKH	RESF1	286	Q9HCM1
ANLHFPSVYVEQKTT	SAMD9	461	Q5K651
ATYNGPKHSLTQISQ	TAF1L	1476	Q8IZX4
KLYNTTTVVPVNHIF	NIPAL2	271	Q9H841
QIFAIHQLGPGYKST	NBEA	401	Q8NFP9
PATVHTIGSYFRLNK	FSD2	556	A1L4K1
PSLDNHQVSAKYIGS	CDC40	141	O60508
PSSHYVITLKAFNNV	NEO1	801	Q92859
VNTEVKANGPHLYSS	PHF12	541	Q96QT6
KEEGHPNTFTSYLQV	PKD1L3	256	Q7Z443
SKVYIVSHSSGQQVP	SIPA1L2	1366	Q9P2F8
YAPQKVAISIFQGNS	SIGLEC6	236	O43699
SVKLNIVISPYHFDN	SHPRH	96	Q149N8
NNHTLFGVLNYTKTP	MSH4	331	O15457
TQHAPYFKGTAVVNG	PRDX3	66	P30048
PLEHYLFTGNSSKTQ	SKIV2L	486	Q15477
KIIFHSGPTNSGKTY	SUPV3L1	201	Q8IYB8
PLQYHVTQEKGTESA	MSRB3	56	Q8IXL7
NTIISHYDGRQFPKV	NOP2	436	P46087
VKVLAESNPTHYGFL	PEX12	41	O00623
LIYNQKEGHFPRVTT	SIRPG	76	Q9P1W8
NQLYPGESFAHSIKT	PRORP	311	O15091
SQLHGSTKYIIDPQN	SNRK	656	Q9NRH2
KTAGYPNVNIHNFTT	SPTBN1	186	Q01082
PKTQFLGVYFVSSQE	ABCC8	336	Q09428
KAIGPVTNYSVATHV	HTR3D	51	Q70Z44
EYQIKTFSGQTHGFV	CMBL	201	Q96DG6
QPFLEKYQTIHSTGF	C15orf39	211	Q6ZRI6
VHTSYGPITVYFLNK	C15orf61	136	A6NNL5
FQVAYVVFQKPSGVS	RRP7A	116	Q9Y3A4
KISHTTGIPYNSQGQ	ERVK-25	726	P63136
KVAFTTRIYHPNINS	UBE2D2	66	P62837
PFIQHIYQKGTSTIS	ZNF596	86	Q8TC21
STLHSQFIRTAQPYK	TRPM6	561	Q9BX84
NDSHTPGTKVYEVVN	USP16	596	Q9Y5T5
TQSHGVKLTPAQYQG	ZFHX2	256	Q9C0A1
LSYILVVSQGSKHNP	NME8	221	Q8N427
TGIFIHQVVAKPSVY	SPIN4	216	Q56A73
LGHSYLVTSPVNQEK	SPATA31D1	1046	Q6ZQQ2
TKIAVDTAAGPYQNH	SEMA6A	421	Q9H2E6
PYQNHTVVFLGSEKG	SEMA6A	431	Q9H2E6
SPSTHYTAKIQALNG	TNC	1946	P24821
KVAFTTRIYHPNINS	UBE2D3	66	P61077
PSKDTTLIHQIFGGY	USP17L13	186	C9JLJ4
FYRLHFKIPQTNVSV	ACP5	136	P13686
YPVGKHAVQTTLESA	TENM3	1391	Q9P273
KTAGYPHVNVTNFTS	SPTB	186	P11277
GHFPCKVLSVNYTAI	PKHD1L1	1696	Q86WI1
QPSLTSVNGFHSKYA	TET3	1266	O43151
AGTSHDVKPFSQQTY	TEAD4	171	Q15561
TYNKHLFVHIGQSSP	TEAD4	241	Q15561
SVFPAHKGVLAAYSQ	ZBTB47	26	Q9UFB7
LSAYQVTNLVPGTKF	UPK2	101	O00526
SNTHISNSLFYPLGK	ZGRF1	756	Q86YA3
IPAVFQSPAHYKQTF	ZGRF1	1286	Q86YA3
GHSISKPNVISYLEQ	ZNF566	46	Q969W8
KISHTTGIPYNSQGQ	ERVK-19	731	Q9WJR5
LFIPQITTKHSGLYV	PSG2	286	P11465
PQRVKFTVTTGHYTI	TRAPPC10	801	P48553
KVAFTTKIYHPNINS	UBE2D4	66	Q9Y2X8
SPQFHKVTVAGISIY	YIPF2	156	Q9BWQ6
FTPANAVIGHYTLKI	TGM7	106	Q96PF1
GPSFKSVNTSVHIYD	FLT1	316	P17948
PRKQQGYSTVSHFNI	UBR4	4871	Q5T4S7
HEKDTSYSSGIPVQQ	ZNF235	296	Q14590
IADNPTFGIVLSKYH	TERB1	281	Q8NA31
FIKTYPAHQNRVSAI	WDFY1	106	Q8IWB7
TVHEKYQGQAPSVFS	TYK2	1171	P29597
IVRGVKYNQATPNFH	VASP	66	P50552
SAKQIFRQPGHTIYL	VPS13D	3166	Q5THJ4
YTGQHFNIPAITKAG	KYNU	226	Q16719